Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-042835
Filing Date
2025-04-30
Accepted
2025-04-30 21:53:04
Documents
1
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2513680-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2513680-4_3seq1.xml 3 1485
  Complete submission text file 0001104659-25-042835.txt   3045
Mailing Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623
Business Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623 213-273-5453
Liminatus Pharma, Inc. (Issuer) CIK: 0001971387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O LIMINATUS PHARMA, INC. 6 CENTERPOINTE DRIVE #625 LA PALMA CA 90623
Business Address
Baek Ji Yeon (Reporting) CIK: 0002063791 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42626 | Film No.: 25899062